Moderna Stock Down 39% in Three Months: Buy the Dip or Wait?
Portfolio Pulse from
Moderna's stock has dropped 39% in the past three months due to lowered long-term financial guidance and a delayed breakeven point to 2028.
December 23, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Moderna's stock has decreased by 39% over the last three months following a reduction in its long-term financial guidance and a delay in its breakeven point to 2028.
The significant drop in Moderna's stock price is attributed to the company's announcement of lowered financial expectations and a postponed breakeven point. This news is likely to negatively impact investor sentiment in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100